The WACC of Cue Biopharma Inc (CUE) is 8.2%.
| Range | Selected | |
| Cost of equity | 6.90% - 9.80% | 8.35% |
| Tax rate | 0.30% - 0.70% | 0.50% |
| Cost of debt | 7.00% - 7.00% | 7.00% |
| WACC | 6.9% - 9.5% | 8.2% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.66 | 0.88 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.90% | 9.80% |
| Tax rate | 0.30% | 0.70% |
| Debt/Equity ratio | 0.13 | 0.13 |
| Cost of debt | 7.00% | 7.00% |
| After-tax WACC | 6.9% | 9.5% |
| Selected WACC | 8.2% | |